How A 3-Firm 'Joint Effort' Beat A $3.6B Pharma Antitrust Suit
With Gilead and Teva facing trial on claims they bilked health plans and insurers out of $3.6 billion through a "pay-for-delay" scheme over two HIV drugs, the three law firms representing...To view the full article, register now.
Already a subscriber? Click here to view full article